Showing results (101-110 of 4,133) with videos related to

Sort By:
Pageof 414
Expert Opinion on Pharmacotherapy|February 25, 2009
High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosisHans-Peter Hartung
ALTEX|December 7, 2000
New Applications of the Human Whole Blood Pyrogen Assay (PyroCheck)Fennrich, Wendel, Hartung
Brain, Behavior, and Immunity|December 1, 1988
Activation of macrophages by neuropeptidesH P Hartung
Current Neurology and Neuroscience Reports|May 5, 2021
Economics of Multiple Sclerosis Disease-Modifying Therapies in the USADaniel M Hartung
Pediatric Nephrology (Berlin, Germany)|May 19, 2015
Biomarkers and surrogate endpoints in kidney diseaseErum A Hartung
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 17, 2017
Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USADaniel M Hartung
Journal of Neurology|September 20, 2005
Early treatment and dose optimisation BENEFIT and BEYONDHans-Peter Hartung
Annals of Neurology|June 1, 1993
Immune-mediated demyelinationH P Hartung
Nucleic Acids Research|April 16, 2010
Quantitative analysis of processive RNA degradation by the archaeal RNA exosomeSophia Hartung, Theresa Niederberger, Marianne Hartung, et al.
The Journal of the Acoustical Society of America|September 27, 2001
Peripheral auditory processing and investigations of the "precedence effect" which utilize successive transient stimuliK Hartung, C Trahiotis
Pageof 414